CL2010001424A1 - Compounds derived from azacarbolines; intermediate compounds; pharmaceutical composition; preparation procedure; and its use in the treatment of cancer. - Google Patents

Compounds derived from azacarbolines; intermediate compounds; pharmaceutical composition; preparation procedure; and its use in the treatment of cancer.

Info

Publication number
CL2010001424A1
CL2010001424A1 CL2010001424A CL2010001424A CL2010001424A1 CL 2010001424 A1 CL2010001424 A1 CL 2010001424A1 CL 2010001424 A CL2010001424 A CL 2010001424A CL 2010001424 A CL2010001424 A CL 2010001424A CL 2010001424 A1 CL2010001424 A1 CL 2010001424A1
Authority
CL
Chile
Prior art keywords
compounds
azacarbolines
cancer
treatment
pharmaceutical composition
Prior art date
Application number
CL2010001424A
Other languages
Spanish (es)
Inventor
Serge Mignani
Thierry Gouyon
Didier Babin
Christopher Arendt
Olivier Bedel
Mikhall Levit
Ronghua Li
Neil Moorcroft
Papin
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of CL2010001424A1 publication Critical patent/CL2010001424A1/en

Links

Abstract

Compuestos derivados de azacarbolinas; compuestos intermediarios; composición farmacéutica; procedimiento de preparación; y su uso en el tratamiento del cáncer.Compounds derived from azacarbolines; intermediate compounds; pharmaceutical composition; preparation procedure; and its use in the treatment of cancer.

CL2010001424A 2008-06-12 2010-12-10 Compounds derived from azacarbolines; intermediate compounds; pharmaceutical composition; preparation procedure; and its use in the treatment of cancer. CL2010001424A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0836262 2008-06-12

Publications (1)

Publication Number Publication Date
CL2010001424A1 true CL2010001424A1 (en) 2011-08-12

Family

ID=69191697

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2010001424A CL2010001424A1 (en) 2008-06-12 2010-12-10 Compounds derived from azacarbolines; intermediate compounds; pharmaceutical composition; preparation procedure; and its use in the treatment of cancer.

Country Status (1)

Country Link
CL (1) CL2010001424A1 (en)

Similar Documents

Publication Publication Date Title
CL2013000016A1 (en) Compounds derived from imidazopyridine; preparation procedure; Pharmaceutical composition and its use in the treatment of cancer.
CL2012001405A1 (en) Spiroindolinone-pyrrolidine derived compounds; obtaining process; pharmaceutical composition; and use in the treatment or prophylaxis of cancer.
CL2008001373A1 (en) Compounds derived from substituted phenylamino-benzene; Preparation method; pharmaceutical composition; farm kit; and use of said compounds in the treatment of cancer.
CL2008001540A1 (en) Compounds derived from pyrrolopyridines and pyrazolopyridines; pharmaceutical composition; and use in the treatment of cancer.
CL2013000018A1 (en) Compounds derived from indolizine, their preparation procedure; pharmaceutical composition; and use in the treatment of cancer, among others.
CL2008001076A1 (en) COMPOUNDS DERIVED FROM SULFONAMIDE; PHARMACEUTICAL COMPOSITION; AND USE IN THE TREATMENT OF CANCER.
CL2007000806A1 (en) COMPOUNDS DERIVED FROM REPLACED HETEROPENTACICLOS; PREPARATION PROCESS; INTERMEDIARY COMPOUNDS; PHARMACEUTICAL COMPOSITION; AND USE IN THE TREATMENT OF CANCER.
CL2011003229A1 (en) Conjugated compounds derived from cryptophycin; preparation procedure; and its use for the treatment of cancer.
CL2008001633A1 (en) Compounds derived from pyrrolidin-3-carboxamide; pharmaceutical composition; and use as erk inhibitors for the treatment of cancer.
CL2012003026A1 (en) Pharmaceutical composition comprising pioglitazone and linagliptin; preparation procedure; Use in the treatment of type 2 diabetes or obesity.
CL2012002250A1 (en) Fused heterocyclic compounds derived from pyrimidinones, potent inhibitors of cdc7; pharmaceutical composition; and its use in the prevention or treatment of cancer.
CL2012000772A1 (en) Compounds derived from substituted carboxyamide heterocycles, ar antagonist; pharmaceutical composition comprising them; and use in the treatment of prostate cancer.
BRPI0915084B8 (en) compound, and, pharmaceutical composition
CL2009000200A1 (en) Compounds derived from 2,7-naphthyridines-1-one, mediators of syk; pharmaceutical composition; and use in the treatment of inflammatory, respiratory, cellular proliferative or autoimmune disease.
CL2008000670A1 (en) Compounds derived from thiazolidinediones and substituted oxazolidinediones; pharmaceutical composition; process of preparation of the pharmaceutical composition; and use in the treatment of diseases such as rheumatoid arthritis, epoc, cancer, among others.
CL2011003350A1 (en) Nitrogenous heterocycle derivative compounds, pkm2 modulators; pharmaceutical composition comprising them; and its use in the treatment of cancer.
CL2009001274A1 (en) Substituted triazine-derived compounds, mediated by inhibition of p13 and mtor kinase; pharmaceutical composition; preparation procedure; and its use in the treatment of different types of cancer.
CL2009000119A1 (en) Compounds derived from substituted amino-benzimidazoles; pharmaceutical composition; and its use in the treatment of Alzheimer's.
CL2011002942A1 (en) Compounds derived from 2,4-diamino-pyrimidine, toll-7 (tlr7) receptor agonists; pharmaceutical composition; and its use for the treatment of cancer.
CL2008001123A1 (en) Compounds derived from lipoic acid; pharmaceutical formulation comprising it; and use in the treatment of cancer.
CL2007002207A1 (en) COMPOUNDS DERIVED FROM SULFONYLAMINES; PHARMACEUTICAL COMPOSITION; AND USE OF COMPOUNDS IN THE TREATMENT OF GLAUCOMA.
CL2011000846A1 (en) Heterocyclic Substituted Compounds; pharmaceutical composition; and its use for the treatment of hepatitis c.
CL2011000116A1 (en) Compounds derived from imidazo [1,2-a] pyridine; preparation procedure; pharmaceutical composition; intermediate compounds; and use in the treatment of cancer.
CL2014002557A1 (en) Bicyclic compounds of pyrazinone; preparation procedure; pharmaceutical composition; kit; and use in the treatment and / or prevention of cardiovascular diseases, cancer, among others.
CL2011000119A1 (en) Compounds derived from triazolo [4,3-a] pyridine; preparation procedure; pharmaceutical composition; and use in the treatment of diseases such as cancer.